DYAI-100

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameDYAI-100
Drug Alias NameDYAI-100SARS-CoV-2 S-RBD
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaDiscontinued
Originator CompaniesDyadic International Inc
China Registration ClassN/A

Develop Information

Active CompaniesRubic Consortium (Pty) Ltd
Inactive CompaniesChengdu WestVac Biopharma Co Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A